Patients with affected devices should stop using them. They are eligible for free replacements, Abbott said.

The U.S. Food and Drug Administration has issued a recall of glucose monitors used by those with diabetes for malfunctioning.

A subset of FreeStyle Libre 3 and Libre 3 Plus sensors can give falsely low glucose readings, with 736 serious adverse events and seven deaths reported worldwide. Only specific Libre 3 and Libre 3 ...

The decision to recall approximately three million sensors follows reports of potentially life-threatening errors in the ...

The U.S. Food and Drug Administration warned people to stop using certain types of glucose monitor sensors that were linked ...

The Food and Drug Administration issued an “early alert” concerning FreeStyle Libre 3 and FreeStyle Libre Plus sensors used ...

The correction relates to around three million sensors used in Abbott’s FreeStyle Libre 3 and Libre 3 Plus CGMs in the US.

Tandem Diabetes Care begins global commercial rollout of t:slim X2 pump integration with the FreeStyle Libre 3 Plus CGM sensor, expanding choice and personalization for people living with diabetes ...

Abbott is asking users of its FreeStyle Libre 3 diabetes monitors to check the serial numbers of their sensors after the company found that a limited number could provide incorrectly high glucose ...

The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes. The Food and Drug Administration (FDA) has ...

Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...

Some FreeStyle Libre 3 glucose sensors made by Abbott Diabetes Care may give incorrect low readings. The devices have been ...